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Background: The incorporation of histone variants into nucleosomes is one of the main strategies that the cell
uses to regulate the structure and function of chromatin. Histone H2A.Z is an evolutionarily conserved histone H2A
variant that is preferentially localized within nucleosomes at the transcriptional start site (TSS). H2A.Z reorganizes the
local chromatin structure and recruits the transcriptional machinery for gene activation. High expression of H2A.Z
has been reported in several types of cancers and is causally linked to genomic instability and tumorigenesis.
However, it is not entirely clear how H2A.Z overexpression in cancer cells establishes aberrant chromatin states
and promotes gene expression.
Results: Through integration of genome-wide H2A.Z ChIP-seq data with microarray data, we demonstrate that
H2A.Z is enriched around the TSS of cell cycle regulatory genes in bladder cancer cells, and this enrichment is
correlated with the elevated expression of cancer-promoting genes. RNAi-mediated knockdown of H2A.Z in the
cancer cells causes transcriptional suppression of multiple cell cycle regulatory genes with a distinct decrease in
cell proliferation. H2A.Z nucleosomes around the TSS have higher levels of H3K4me2/me3, which coincides with
the recruitment of two chromatin factors, WDR5 and BPTF. The observed recruitment is functional, as the active
states of H2A.Z target genes are largely erased by suppressing the expression of WDR5 or BPTF, effects resembling
H2A.Z knockdown.
Conclusions: We conclude that H2A.Z is overexpressed in bladder cancer cells and contributes to cancer-related
transcription pathways. We also provide evidence in support of the engagement of H3K4me2/me3 and WDR5/BPTF
in H2A.Z-induced cancer pathogenesis. Further studies are warranted to understand how H2A.Z overexpression
contributes to the recruitment of the full repertoire of transcription machinery to target genes in bladder cancer cells.
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Gene expression in eukaryotes takes place in the context
of chromatin, which essentially acts as a physical barrier
to the binding of transcription factors to certain genomic
regions. The basic unit of chromatin is the nucleosome,
which consists of approximately 147 bp of DNA wrapped
around an octamer of four core histones (H2A, H2B,
H3, and H4) [1]. Despite its high degree of compaction,
chromatin structure is dynamically modulated to allow
access of genomic DNA during vital cellular processes.
Several remodeling processes that alter chromatin
structure have been identified and categorized based on* Correspondence: woojinan@usc.edu
1Department of Biochemistry and Molecular Biology, Norris Comprehensive
Cancer Center, 1450 Biggy Street, Los Angeles, CA 90033, USA
Full list of author information is available at the end of the article
© 2013 Kim et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the ortheir modes of action. The three most prominent processes
are histone modification, histone variant exchange and
adenosine triphosphate (ATP)-dependent chromatin
remodeling [2-5]. Histone variants are nonallelic isoforms
of canonical core histones that have been identified
primarily from the H2A and H3 families in numerous
organisms. Although expressed in smaller amounts
than canonical histones, histone variants are involved
in a variety of cellular activities with specific genomic
localization patterns.
H2A.Z is an essential variant of the histone H2A and
has distinct functions in regulating chromatin dynamics.
At the amino acid sequence level, H2A.Z shares about
60% identity with canonical H2A in mammalian cells
[6]. As for other histone variants, the replacement of
histone H2A with H2A.Z is replication-independent and. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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preferentially localizes at the transcription start site
(TSS) where it frequently flanks nucleosome-deficient
regions [7-11]. The presence of H2A.Z at the −1 and +1
nucleosomes adjacent to the TSS has been linked to
dynamic changes in gene expression [12-15], but the
underlying mechanism is not fully understood. Since
H2A.Z-containing nucleosomes wrap DNA more weakly
than canonical H2A nucleosomes, they are more suscep-
tible to nuclease digestion and salt-induced destabilization
[16,17]. This structural instability is most likely driven
by amino acid substitutions at the interface between
H2A.Z and H3/H4 [18]. Consistent with its effects on
gene transcription, the presence of H2A.Z correlates with
active histone modifications and RNA Pol II occupancy at
gene promoters, which in turn influence transcriptional
output [7,13,19]. These observations are in agreement with
the concept that H2A.Z creates an active transcription
environment by altering DNA accessibility in chromatin
and facilitating the recruitment of transcription regulators.
Of special relevance to the present study, overexpression
and redistribution of H2A.Z have been noted as epigenetic
processes to stimulate the development and progression
of certain types of cancer [20-23]. The oncogenic function
of H2A.Z is mediated through increased cell proliferation
caused by cell cycle deregulation. Therefore, the important
questions to address are how H2A.Z maintains chromatin
in a certain state, and whether H2A.Z overexpression
observed in cancer cells drives the inappropriate activation
of cancer-related genes.
In this work, we exploited microarray and chromatin
immunoprecipitation sequencing (ChIP-seq) to examine
the impact of H2A.Z overexpression on transcriptional
states of bladder cancer cells, and identified groups of
genes, the dysregulation of which is linked to H2A.Z
enrichment around the TSS. We also found that H2A.Z
nucleosomes are enriched for the active histone modifica-
tion H3K4me2/me3 that is likely responsible for recruiting
WDR5 and BPTF to H2A.Z target genes.
Results
H2A.Z is overexpressed in bladder cancer cells and
stimulates cell proliferation
As H2A.Z expression is often misregulated in cancer
cells, we first examined H2A.Z levels in human bladder
cell lines by Western blot. H2A.Z was expressed at much
higher levels in the six bladder cancer cell lines (SCaBER,
J82, LD611, RT4, HT1376 and T24) compared to the
normal bladder cell line UROtsa (Figure 1A). Another
demonstration of the relationship between H2A.Z over-
expression and tumorigenesis came from the results
obtained from immunohistochemical analysis of tissue
microarrays containing 16 bladder cancer samples and
8 normal control samples. As illustrated in Figures 1Band 1C, the staining for H2A.Z was strong or moderate
in the majority of bladder tumor tissues (approximately
90%), while the staining was weak or negative in most
normal tissues (approximately 85%).
We next checked whether the high-level expression of
H2A.Z in cancer cells contributes to cell growth over a
period of four days. The 3–4, 5-(dimethyl-thyazol-2-yl)-2,
5-diphenyltetrazolium (MTT) assays reproducibly showed
that LD611 cancer cells expressing high levels of H2A.Z
grow much faster compared to normal UROtsa cells
(Figure 1D). These findings were further corroborated
by the results showing that the ectopic expression of
H2A.Z led to a significant increase in the growth of
UROtsa cells (Figure 1E and Additional file 1: Figure
S1). To evaluate the effects of H2A.Z overexpression
more directly, endogenous H2A.Z was depleted in LD611
cells by using a lentiviral shRNA infection system, and
changes in cell growth were analyzed. Western blotting
confirmed that the stable transfection of H2A.Z
shRNA efficiently silenced H2A.Z expression in the
cell (Additional file 1: Figure S2). The MTT assays
clearly showed that suppressing H2A.Z expression
decreased the growth of LD611 cells (Figure 1F).
These observations are consistent with the hypothesis that
H2A.Z is one of the key players governing proliferation
of bladder cancer cells.
H2A.Z shows a unique localization pattern in bladder
cancer cells
To gain mechanistic insights into the observed effects of
H2A.Z, we conducted ChIP-seq of H2A.Z in the LD611
cancer cell line. The UROtsa cell line was used as a normal
control to identify the genomic redistribution of H2A.Z
in the cancer cell line. We compared the average ChIP
enrichment signals over the regions spanning 10 kb
around the TSS of all human genes as detailed in the
Methods. As expected, H2A.Z occupied nucleosomes
surrounding the TSS in both normal and cancer cells
(Figure 2A). However, the enrichment of H2A.Z was
more pronounced in the bladder cancer cells than in the
normal cells. Heatmap analysis with k-means clustering of
ChIP-seq datasets also indicated that H2A.Z nucleosomes
were more highly enriched in the immediate upstream
and downstream of the TSS in the cancer cells (Figure 2B).
To distinguish the H2A.Z enrichment from the genomic
background, the expectation maximization-based curve
fitting method that uses the normalized locus-specific
chromatin state (NLCS) was employed as detailed previ-
ously [24]. Based on the log2 transformed NLCS values
and false discovery rate (FDR), we found that 750 and 200
genes were enriched for H2A.Z in the cancer and normal
cells, respectively. To identify the genes involved in
bladder cancer development, we further classified the
cancer-specific genes into the four distinct groups
Figure 1 H2A.Z overexpression and bladder cancer cell growth. (A) Normal (UROtsa) and bladder cancer (SCaBER, J82, LD611, RT4, HT1376
and T24) cells were lysed in RIPA buffer, and equal amounts of lysates were analyzed by Western blot using anti-H2A.Z antibody. Actin served as
a control for equal protein loading. (B) Tissue microarrays containing 16 bladder tumor and 8 normal tissue samples were subjected to
immunohistochemistry with H2A.Z antibody. Representative high-powered images are shown. (C) Immunostaining scores of H2A.Z in normal
and bladder cancer tissues. The graph indicates the percentage of sections with different scores (negative, weak, moderate and strong). (D)
Proliferation of UROtsa and LD611 cells was determined by MTT colorimetric assays at the indicated time points. Data shown represent mean ± SD
from three replicates. (E) UROtsa cells were transfected with H2A.Z as in Additional file 1: Figure S1, and cell proliferation was measured by MTT assay
over a period of four days. All reactions were performed in triplicate. (F) LD611 cells were mock-depleted or depleted of H2A.Z as in Additional file 1:
Figure S2, and cell proliferation was monitored by MTT assays over a period of four days. MTT assay, 3–4, 5-(dimethyl-thyazol-2-yl)-2,
5-diphenyltetrazolium assay.
Kim et al. Epigenetics & Chromatin 2013, 6:34 Page 3 of 13
http://www.epigeneticsandchromatin.com/content/6/1/34based on their FDR values and NLCS. A total of 480
out of 750 genes were classified into the groups 1, 2 and 3
with P <0.05, suggesting that these genes are specifically
enriched for H2A.Z in the bladder cancer cells (Figure 2C
and Additional file 2: Table S1). To validate ChIP-seq
results, we chose three H2A.Z-enriched genes in the
normal and cancer cells and carried out conventional
ChIP assays. Expectedly, H2A.Z was detected around
the TSS of these genes in both cell lines (Additional file 1:
Figure S4). Ingenuity pathway analysis also identified a set
of genes related to bladder cancer signaling as well as
DNA repair (Figure 2D).H2A.Z redistribution correlates with increased expression
of proliferation-related genes
The aberrant enrichment of H2A.Z within nucleosomes
adjacent to the TSS in the bladder cancer cells suggests
that H2A.Z may establish distinct transcription states.
To interrogate this possibility, we conducted gene expres-
sion profiling with total RNA isolated from the normal
and cancer cell lines. Our detailed comparison of thetranscriptional profiles identified a large number of differ-
entially expressed genes in the bladder cancer cells, with
2,115 genes being upregulated and 2,070 genes being
downregulated (Figure 3A and Additional file 3: Table
S2). Quantitative reverse transcription polymerase
chain reaction (qRT-PCR) analyses of six upregulated,
six downregulated and six unaffected genes validated
our microarray results (Additional file 1: Figure S5).
To infer which of the genes showing altered expres-
sion in the cancer cells were potentially regulated by
H2A.Z, we combined the ChIP-seq and gene expres-
sion data. Among the 2,115 genes upregulated in the
cancer cells, 133 genes exhibited higher levels of H2A.Z.
Conversely, only 23 genes out of the 2,069 downregulated
genes showed H2A.Z enrichment (Figure 3A and Add-
itional file 4: Table S3). In light of the fact that the ac-
quisition of H2A.Z around the TSS is mainly correlated
with gene activation, we decided to focus on the
upregulated genes. Functional annotation of differen-
tially expressed genes using ingenuity pathway analysis in-
dicated that genes involved in cell growth and proliferation
are significantly enriched in this category (Figure 3B).
Figure 2 H2A.Z localization patterns in bladder cancer cells. (A) Average chromatin immunoprecipitation (ChIP) enrichment signals are
shown over regions spanning 10 kb around the transcription start sites (TSSs) of all the human genes from UCSC Refseq database. Green and red
lines indicate the level of H2A.Z enrichment in normal UROtsa and cancer LD611 cells, respectively. (B) Tag density plots display H2A.Z
distribution relative to the TSS. Several representative peaks specific for LD611 and UROtsa cells were also shown. Each horizontal line represents
an individual gene, and the enrichment values for H2A.Z are illustrated by color density. (C) H2A.Z-enriched genes in LD611 cells were classified
into four distinct groups based on false discovery rate (FDR) and the level of locus-specific chromatin state (NLCS) density. Groups 1 and 2 show
NLCS ratio ≥8.5 and 8 to 8.5 with FDR ≤0.01 and FDR ≤0.05, respectively. Group 3 has FDR ≤0.05 with NLCS level from 7.5 to 8.5. Group 4 has
FDR ≥0.05 with NLCS ≤8. (D) H2A.Z-enriched genes in LD611 cells were subjected to ingenuity pathway analysis. Seven top biological functions
including bladder cancer signaling were identified with a threshold set at P = 0.05.
Kim et al. Epigenetics & Chromatin 2013, 6:34 Page 4 of 13
http://www.epigeneticsandchromatin.com/content/6/1/34When we analyzed a group of the positively regulated
proto-oncogenes (BIRC3, CCND, DDX43, FADD, MEN1,
NT5E, POLDIP2, PPFIA1, STK3, and YAP1), we detected
a robust signal for H2A.Z around the TSS (Figure 3C,
LD611). In the normal bladder cells, these genes
displayed much lower levels of H2A.Z (UROtsa). To
further validate the ChIP-seq and gene expression
data, we selected the 10 active genes from the H2A.Z
regulon and performed conventional ChIP assays.
Expectedly, H2A.Z enrichment was evident in these
genes in the bladder cancer cells, but similar assays in
the normal cells showed minimal accumulation of
H2A.Z (Figure 3D). Moreover, there was a significant
correlation between H2A.Z enrichment and gene acti-
vation, as evidenced by qRT-PCR analysis (Figure 3E).
To the best of our knowledge, this is the first reportlinking H2A.Z enrichment to active transcription
states in bladder cancer cells.
WDR5 and BPTF preferentially interact with H2A.Z
nucleosomes
To study how H2A.Z directs oncogenic transcription in the
bladder cancer cells, we decided to identify proteins that
selectively interact with H2A.Z nucleosomes. Accordingly,
the LD611 cells were transfected with plasmids expressing
Flag/HA-tagged versions of H2A and H2A.Z. After con-
firming the comparable expression of ectopic H2A.Z and
H2A (data not shown), soluble chromatin was prepared
from the transfected cells and digested with micrococcal
nuclease to yield mainly mononucleosomes. Mononuc-
leosomes containing ectopic histones and their bound
proteins were purified by sequential immunoprecipitations
Figure 3 Effects of H2A.Z enrichment on gene expression. (A) Venn diagram shows H2A.Z-enriched genes that are upregulated (133 genes)
and downregulated (23 genes) more than 1.5-fold with a P value of <0.05 in LD611 bladder cells. (B) Functional groups associated with the 133
genes that are enriched by H2A.Z and are upregulated in LD611 cancer cells. Biological processes are graphically depicted by P value. (C)
Representative Integrative Genomics Viewer (IGV) genome browser tracks show the levels of H2A.Z near the TSS in LD611 (red) and UROtsa (blue)
cells. Maximum sequencing depth over the displayed area is indicated on the right side in parentheses along with name of the genes. Different
genomic coordinates and genome window size for BIRC3 (chr11:101,691,391-101,717,344; 26 kb); CCND1 (chr11:69,163,054-69,180,423; 17 kb);
DDX43 (chr6:74,159,006-74,186,010; 26 kb); FADD (chr11:69,724,917-69,733,156; 8 kb); MEN1 (chr11:64,325,562-64,337,342; 11 kb); NT5E
(chr6:86,214,021-86,264,228; 50 kb); POLDIP2 (chr17:23,695,786-23,710,730; 15 kb); PPFIA1 (chr11:69,792,454-69,910,255; 118 kb); STK3
(chr8:99,505,659-99,937,462; 432 kb) and YAP1 (chr11:101,484,402-101,611,364; 127 kb) are shown along with Reference Sequence (RefSeq)
data. (D) LD611 and UROtsa cells were analyzed by quantitative chromatin immunoprecipitation (ChIP) using H2A.Z antibody to validate
ChIP-sequencing results. Immunoprecipitated DNA was amplified by quantitative PCR (qPCR) with primers specific for the 10 genes. The primers
are listed in Additional file 6: Table S5. Percent input was determined as the amount of immunoprecipitated DNA relative to input DNA. Error
bars represent standard deviation of three independent experiments. (E) The RNA samples from LD611 and UROtsa cells were analyzed by
quantitative reverse transcription PCR (qRT-PCR) using primers listed in Additional file 6: Table S5. Expression level was normalized to that of actin,
and average and standard deviation of three independent experiments are shown.
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conditions (300 mM NaCl and 0.1% NP40). Coomassie
brilliant blue (CBB) staining confirmed the stoichiometry
of H2B, H3, H4 and ectopic H2A/H2A.Z in the purified
nucleosomes (Figure 4A, CBB). Western blotting with
H2A and H2A.Z antibodies also indicated that ectopic
H2A and H2A.Z were incorporated into nucleosomes
at levels substantially higher than their endogenous
counterparts (α-H2A and α-H2A.Z). Silver staining ofan SDS-polyacrylamide gel containing the proteins that
were co-purified with H2A or H2A.Z nucleosomes revealed
the presence of multiple extra bands specific to H2A.Z
nucleosomes. To identify these extra polypeptides, the puri-
fied proteins were subjected to liquid chromatography-
tandem mass spectrometry (LC-MS/MS). The data
were filtered by excluding any proteins observed in
control pull downs with Flag-HA-tag. This approach
identified 27 proteins specific to H2A.Z nucleosome
Figure 4 Preferential binding of WDR5 and BPTF to H2A.Z nucleosomes. (A) LD611 cells were transfected with H2A and H2A.Z expression
vectors, and mononucleosomes were prepared by MNase digestion as recently described [25]. Mononucleosomes containing ectopic H2A
(lane 1) and H2A.Z (lane 2) were sequentially immunoprecipitated from total mononucleosomes with anti-Flag and anti-HA antibodies. Histone
compositions of the purified nucleosomes were analyzed by 15% SDS-PAGE followed by Coomassie brilliant blue (CBB) staining. The relative
levels of endogenous/ectopic H2A and H2A.Z in the purified nucleosomes were determined by Western blotting using H2A and H2A.Z antibodies.
(B) The proteins co-purified with H2A and H2A.Z nucleosomes were resolved in 4 to 20% SDS-polyacrylamide gels, and then visualized by silver
staining. (C) Venn diagram depicts the number of proteins associated with H2A nucleosomes (65), H2A.Z nucleosomes (85) and those in common (58).
(D) The proteins specifically co-purified with H2A.Z nucleosomes were functionally classified by gene ontology analysis. The number of proteins in
each functional group is shown. (E) The preferential binding of WDR5 and BPTF to H2A.Z nucleosomes were analyzed by Western blotting. (F)
Mononucleosomes containing ectopic H2A or H2A.Z were purified as in (A), and subjected to Western blotting with antibodies specific for the
indicated histone modifications.
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S4). Gene ontology analysis of the proteins revealed
a striking overrepresentation of proteins related to
chromatin reorganization and transcriptional control
(Figure 4D).
A noteworthy observation emerged from our purifica-
tion was substantial interactions of H2A.Z nucleosomes
with WDR5 and BPTF, which are known to interact with
H3K4me tails and play important roles in regulating
chromatin function [26-28]. The observed interactions
are specific, as H2A nucleosomes failed to interact with
these two factors (Figure 4E). Further analyses revealed
that the overall levels of neither H3K9me3 nor
H3K27me3 were altered in H2A.Z nucleosomes (Figure 4F,α-H3K9me3 and α-H3K27me3). However, in the same
nucleosome samples, H2A.Z nucleosomes showed much
higher levels of H3K4me2/me3 as compared to H2A nu-
cleosomes (α-H3K4me2 and α-H3K4me3). These results
underscore the notion that the observed binding of
WDR5 and BPTF depends on their ability to recognize
H2A.Z-facilitated H3K4me2/me3 in the nucleosome.
H2A.Z-mediated gene activation requires WDR5 and BPTF
The fact that WDR5 and BPTF co-purified with H2A.Z
nucleosomes raised the question of whether they play
a potential role in regulating H2A.Z target genes. To
address this question, we individually knocked down
H2A.Z, WDR5, and BPTF in LD611 cancer cells and
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file 1: Figure S2). As expected, qRT-PCR analysis showed
that knockdown of endogenous H2A.Z inactivated the
10 representative target genes (Figure 5A). These genes
were also expressed at much lower levels in cells de-
pleted of either WDR5 or BPTF as compared to con-
trol cells, indicating that WDR5 and BPTF areFigure 5 Cooperative function of H2A.Z, WDR5 and BPTF. (A) After sile
genes, which show higher H2A.Z levels around the transcription start site (
values are expressed as fold changes from the levels in undepleted cells. (B
cells depleted of H2A.Z, WDR5 or BPTF as indicated. (C) LD611 cells deplet
then allowed to migrate toward 10% fetal bovine serum (FBS) in the lower
axis indicates the relative percentage of the migrated cell. Three independ
5-(dimethyl-thyazol-2-yl)-2, 5-diphenyltetrazolium assay.critical for transcriptional activation of the target
genes. The requirements for WDR5 and BPTF were
highly specific, as the two control genes, CASP8 and
SRCAP, were minimally affected by silencing endogen-
ous WDR5 and BPTF.
Because WDR5 and BPTF are necessary for H2A.Z to
upregulate gene transcription in the bladder cancer cells,ncing H2A.Z, WDR5 or BPTF in LD611 cells, the mRNA levels of the 10
TSS) and augmented expression, were quantified by qRT-PCR. The
) MTT proliferation assays were carried out in triplicate using LD611
ed of H2A.Z, WDR5 or BPTF were seeded onto the upper chamber, and
chamber. The migrated cells were photographed and counted. The Y
ent experiments in triplicate wells were performed. MTT assay, 3–4,
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H2A.Z-induced cell growth. As summarized in Figure 5B,
when H2A.Z was depleted in the LD611 cancer cells, the
growth of the cancer cells was significantly inhibited
over a four-day period. More importantly, knockdown
of WDR5 or BPTF had the same inhibitory effect as
knockdown of H2A.Z. In accordance with these results,
individual knockdown of H2A.Z, WDR5 and BPTF also
reduced cell migration severely, displaying about 70%
lower migration than control cells (Figure 5C). Considered
together, these findings demonstrate that H2A.Z functions
cooperatively with WDR5 and BPTF to stimulate the
expression of tumorigenic genes.
H2A.Z is essential for H3K4me and WDR5/BPTF recruitment
To check whether the cooperative functions of WDR5
and BPTF in H2A.Z-activated genes reflect their targeted
recruitment, we next investigated their localization at
H2A.Z target genes by ChIP assays. Cross-linked chro-
matin was isolated from control cells and cells depleted
of H2A.Z, WDR5 or BPTF, and the precipitated DNA was
amplified by qPCR using primers specific for upstream
region (UR), transcription start site (TSS) and coding
region (CR). In agreement with the ChIP-seq data, we
detected high H2A.Z signals around the TSS, but much
reduced signals upstream and downstream of the TSS
in BIRC3 and CCND1 genes (Figure 6A, B, H2A.Z). In
determining regions occupied by WDR5 and BPTF, we
found that their binding was near the TSS and coding
region (WDR5 and BPTF). Consistent with our nucleo-
some purification studies and previous reports linking
H3K4me2/me3 to the recruitment of WDR5 and BPTF
[26-28], the distribution of H3K4me2/me3 at the loci was
similar to those of WDR5 and BPTF (H3K4me2/me3).
These data raised the question of whether colocalization
of WDR5 and BPTF at the target genes is dependent on
H2A.Z-promoted H3K4me2/me3. In fact, the predicted
effects of H2A.Z were confirmed by the observation
that the levels of H3K4me2/me3, WDR5 and BPTF at
the target loci were reduced in response to H2A.Z
knockdown. On the contrary, knockdown of WDR5 or
BPTF did not have substantial effects on H2A.Z occupancy
around the TSS, placing WDR5 and BPTF in later steps of
chromatin remodeling. Moreover, H3K4me3 and BPTF
localization at the target genes decreased sharply upon
WDR5 knockdown, suggesting that BPTF is recruited
to the target genes via its physical recognition of WDR5-
facilitated H3K4me3. Because the conversion of H3K4me2
to H3K4me3 is attenuated in WDR5-depleted cells, we
detected a sharp increase in H3K4me2 over the TSS
and CR of the target genes. As expected from the qRT-PCR
results (Figure 5A), ChIP analysis showed no enrichments
of H2A.Z, WDR5 and BPTF at the CASP8 gene, which
did not alter after individual depletion of H2A.Z, WDR5,and BPTF (Additional file 1: Figure S6). In view of the
importance of H3K4me2/me3 for WDR5/BPTF recruit-
ment, we also suspected that H2A.Z target genes may
be selectively enriched for H3K4me2/me3, WDR5 and
BPTF after ectopic H2A.Z expression in the normal
cells. Indeed, when stably expressed in the UROtsa cells,
ectopic H2A.Z produced a distinct increase in the levels of
H3K4me2/me3 at the target genes and thereby facilitated
the recruitments of WDR5 and BPTF (Additional file 1:
Figures S7A and S7B). Consistent with these data, ectopic
expression of H2A.Z in the normal cells increased target
gene expression and cell migration (Additional file 1:
Figures S7C and S7D). These results strongly argue that
H2A.Z, WDR5 and BPTF function coordinately in regulat-
ing growth-controlling genes and their concerted actions
are linked to H3K4me2/me3.
Discussion
Despite significant efforts to understand altered expression
and functional deregulation of H2A.Z in human cancer,
we are still in the early stages of mechanistic studies for its
contribution toward cancer development. Given the close
correlation between H2A.Z exchange and gene activation
in the context of chromatin, H2A.Z has been implicated
in upregulating the network of genes during carcinogen-
esis. To gain deeper understanding of oncogenic effects of
H2A.Z, we analyzed H2A.Z localization and function in
bladder cancer cells by ChIP-seq and gene expression
array. Our analysis of H2A.Z-enriched genes in bladder
cancer cells revealed a significant overrepresentation
for tumorigenic genes in general. By comparing tran-
scriptional profiles, we found that approximately 28%
of the H2A.Z-enriched genes are activated, whereas
only approximately 5% of the genes are repressed, in
the cancer cells. This is significant because H2A.Z is
known to regulate transcription positively or negatively.
However, the changes in the expression and localization
of H2A.Z in bladder cancer cells mainly correlate with
gene activation, with the most activated genes tending
to be related to cell growth regulation. Thus, our data
favor the mechanism in which the elevated expression and
redistribution of H2A.Z contribute to selective, rather
than general, disruption of transcription integrity in
bladder carcinoma cells. The fact that H2A.Z knockdown
affects the same sets of genes in cancer cells further
confirms that H2A.Z is a critical driving force for the
tumorigenic transcriptional output. This study represents
the first genome-wide analysis of H2A.Z in bladder cancer
cells, and establishes H2A.Z as a key component whose
enrichment near the TSS drives expression of major cell
cycle regulatory genes capable of facilitating cell growth
and proliferation. Recent studies in human osteosarcoma
(U2OS) cell line showed that H2A.Z is incorporated into
the p21 promoter region in p53-dependent manner,
Figure 6 H2A.Z-dependent recruitment of WDR5 and BPTF. H2A.Z, BPTF and WDR5 were depleted from LD611 cells, and chromatin
immunoprecipitation (ChIP) assays of BIRC3 (A) and CCND1 (B) genes were performed using antibodies against H2A.Z, WDR5, BPTF and
H3K4me1/me2/me3. Precipitation efficiencies relative to nonenriched input samples were determined for upstream region (UR), transcription start
site (TSS) and coding region (CR) by qPCR with primers listed in Additional file 6: Table S5. Percentage input is determined as the amount of
immunoprecipitated DNA relative to input DNA.
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p21 induction [29]. However, we did not observe any
significant change in p21 transcription after H2A.Z
knockdown in LD611 cells (data not shown). Furthermore,
our ChIP-seq data indicate that H2A.Z is incorporatedinto p21 promoter nucleosomes at low levels in both
LD611 and UROtsa cells. These results imply that
H2A.Z-catalyzed oncogenic pathway in bladder cancer
cells is minimally dependent on a negative behavior of
H2A.Z toward p21 gene.
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chromatin transcription remains unclear, our interaction
data demonstrated that the presence of H2A.Z in the
nucleosome increases the levels of H3K4me2 and
H3K4me3, marks that are associated with gene activation.
These results are in good agreement with those of
recent studies showing that H2A.Z colocalizes with
active histone modifications in transcription regulatory
regions [7,10,30-32]. It is also conceivable that H2A.Z-
induced H3K4me2/me3 at the TSS coincides with the
recruitment of WDR5 and BPTF, which are essential
components of the MLL H3K4-methyltransferase complex
and the NURD ATP-dependent remodeling complex,
respectively [33-35]. This suggests that H2A.Z is an
integral part of histone modification-mediated factor
recruitment processes and has a direct role in resetting
transcription competency of growth-regulatory genes in
bladder cancer. A recent study reported copurification
of WDR5 with H2A.Z nucleosomes, but BPTF was
absent in the purified H2A.Z nucleosomes [30]. Clearly,
these differences could be due to different purification
approaches (for example, single-step purification using the
Flag-tag moiety in the previous study versus two-step
purification using Flag and HA tags in the current study)
and different wash conditions (150 mM NaCl versus 300
mM NaCl). We speculate that the weak binding of BPTF
to H2A nucleosomes is not preserved under our stringent
purification conditions. It is also noteworthy that H2A.Z
nucleosomes isolated from bladder cancer cells display the
levels of the two repressive histone marks, H3K9me3 and
H3K27me3, similar to those of H2A nucleosomes. Thus,
although further work will be required to gain a complete
understanding of how H2A.Z functionally interacts with
various histone modifications, these findings nevertheless
illustrate that H2A.Z overexpression in bladder cancer
cells is likely to act in concert with active histone modi-
fications which establish constitutive expression of the
target genes.
Conclusions
We show that H2A.Z is overexpressed in bladder cancer
cells and establishes the active states of oncogenic tran-
scription. H2A.Z enrichments at target genes increase
the levels of H3K4me2 and H3K4me3, which in turn
facilitate the recruitments of WDR5 and BPTF. These
results unveil a specific contribution of H2A.Z to chro-
matin remodeling in bladder cancer cells and emphasize
the importance of accurate levels of H2A.Z expression to
prevent the onset of tumorigenesis.
Methods
Cell culture, constructs and antibodies
LD611 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetalbovine serum (FBS). UROtsa cells were cultured in
DMEM containing 2 mg/ml glucose and 5% FBS. For
mammalian expression of H2A and H2A.Z, their cDNAs
were amplified by PCR and ligated into the NheI and
BamHI sites of pIRES expression vector containing 5′
Flag and HA coding sequences. Antibodies used in this
study are as follows: H2A, H2A.Z, H3K4me1 and WDR5
antibodies from Abcam (Cambridge, UK), Actin, HA and
Flag antibodies from Sigma-Aldrich (St Louis, MO, USA),
BPTF antibody from Bethyl Laboratories (Montgomery,
TX, USA), H3K4me3 and H3K9me3 antibodies from
Active Motif (Carlsbad, CA, USA), and H3K27me2 and
H3K27me3 antibodies from Merck Millipore (Darmstadt,
Germany).
Tissue microarrays and immunohistochemistry
The expression patterns of H2A.Z were determined in
human bladder tissue microarrays, which include 16
cases of bladder malignant tissues and eight cases of
normal bladder tissues (US Biomax, Rockville, MA,
USA). The tissues were deparaffinized, treated with 3%
hydrogen peroxide to block endogenous peroxide,
and subjected to antigen retrieval with citrate buffer
(10 mM, pH 6.0). The tissue sections were blocked in 5%
normal goat serum in Tris-buffered saline-Triton X-100
(TBST, 50 mM Tris–HCl, pH 7.5, 150 mM NaCl, and
0.3% Triton X-100) for 30 min at room temperature
and incubated with H2A.Z antibody at 4°C overnight.
Immunodetection was performed using Vectastain
ABC kit (Vector Laboratories, Burlingame, CA, USA)
according to manufacturer’s recommendations. DAB
(Vector Laboratories) and hematoxylin (Sigma-Aldrich)
were used for color development and counterstaining.
The staining intensity was evaluated by semiquantitative
immunohistochemical assessment, and divided into four
categories: negative staining (less than 20% of cells),
weak staining (21 to 50% of cells), moderate staining
(51 to 80% of cells) and strong staining (more than
80% of cells).
ChIP-seq
H2A.Z ChIP for UROtsa normal and LD611 bladder
cancer cell lines (1 × 108 cells) was carried out following
a standard protocol as described previously [36]. Briefly,
cells were fixed for 10 min in 1% formaldehyde, and
chromatin was sheared with a bioruptor (Diagenode,
Denville, NJ, USA) to an average size of 200 to 500 bp.
Lysates were clarified by centrifugation at 20,000 × g for
15 min at 4°C, and incubated with anti-H2A.Z antibody
overnight. Protein A/G agarose beads were added to
protein complexes for 60 min at 4°C. Immunoprecipi-
tates were washed three times in wash buffer (20 mM
Tris–HCl, pH 8.0, 300 mM NaCl, 2 mM EDTA, 0.1%
SDS, and 1% Triton X-100), once in LiCl buffer (10 mM
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M LiCl, and 1% NP-40), twice in TE buffer (10 mM
Tris–HCl, pH 8.0 and 1 mM EDTA) and then eluted in
elution buffer (1% SDS and 0.1 M NaHCO3). Crosslinking
was reversed by overnight incubation at 65°C. After RNase
A (200 μg/ml) and proteinase K (200 μg/ml) digestions,
ChIP DNA was purified by phenol-chloroform extraction
and ethanol precipitation. The high-throughput DNA
sequencing was performed using Illumina HiSeq 2000
(Illumina, San Diego, CA, USA) at the University of
Southern California (USC) Genomic Core.
ChIP-seq data analysis
Approximately 17 and 13 million sequences were gener-
ated for the normal and cancer cells, respectively. MAQ
was used to generate 14 and 11 million aligned reads to
hg18 reference genome (mapping quality score ≥20) [37].
One of the duplicated sequences was kept to minimize the
artifacts of PCR amplification. Since we used single-end
sequencing, each read was extended in the sequencing
orientation to a total of 250 bases to infer the coverage
at each genomic position. The genome was divided into
non-overlapping windows, and aligned read was consid-
ered to be within a window of the midpoint of its estimated
fragment. Mid-points in each window were counted, and
empirical distributions of windows counts were created.
The Java-based EpiChIP software was used to identify
optimal sequence window with respect to gene coordi-
nates for analysis of H2A.Z enrichment at all Reference
Sequence (RefSeq) genes. In this analysis, normalized
ChIP-seq signal for each gene (area below the peak and
within window) was quantified to yield NLCS (normalized
locus-specific chromatin state) value by using expectation
and maximization algorithm and a curve fitting model
of Baysen information criteria as previously described
[24,38]. The mapping output files were also converted
to browser-extensible data (BED) files. For visualization,
wiggle tracks were generated by computing mean read
density over 25 bp bins of human genome with aligned
and filtered reads from UROtsa and LD611 ChIP-seq data.
Wiggle tracks were visualized in the IGV (Integrated
Genomic Viewer) [39]. K-means clustering was performed
on ChIP-seq tag density around 3 kb regions across the
TSS in R statistical software (http://www.r-project.org).
Gene expression microarray
Total RNA was isolated from LD611 and UROtsa cells
using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA).
Gene expression microarray experiments were conducted
using a whole-genome expression array (Human HT-12
v4 Expression BeadChip; Illumina). This high-density
oligonucleotide array chip targets more than 47,000
probe sequences derived from National Center for Bio-
technology Information Reference Sequence (NCBI)RefSeq Release 38 (November 7, 2009) and other sources.
Data were background-corrected using Genome Studio
(Illumina) and were quantile-normalized. Genes showing
detection P <0.05 with fold change >1.5 were selected as
suggested by the manufacturer (Illumina). Genes which
are differentially associated with H2A.Z in LD611 cancer
cells were functionally analyzed in the context of gene
ontology and molecular networks by using Ingenuity
pathway software (IPA; www.ingenuity.com). Differen-
tially regulated genes were categorized into various
functional groups (threshold P <0.05) and mapped to
genetic networks.RNA interference, qRT-PCR, and ChIP
For shRNA-based knockdown, DNA oligonucleotides
encoding shRNAs specific for H2A.Z mRNA (5′-GC
TTCAAAGAAGCTATTGATT-3′), WDR5 (5′-GAGAG
TGGCTGGCAAGTTCAT-3′) and BPTF mRNA
(5′-CGCCACTAACAGAGAAGGATT-3′) were annealed
and ligated into the lentiviral expression vector pLKO.1
(Addgene, Cambridge, MA, USA). Lentivirus particles
were generated in 293T cells by co-transfecting plasmids
encoding VSV-G, NL-BH and the shRNAs. For H2A.Z,
WDR5 and BPTF knockdown, LD611 cells were infected
with these viruses and selected with puromycin (2 μg/ml)
for two weeks. For qRT-PCR, total RNA (2 μg) was reverse
transcribed using the iScript cDNA Synthesis Kit (Bio-Rad
Laboratories, Hercules, CA, USA) and the PerfeCta™
SYBR Green FastMix (Quanta BioSciences Gaithersburg,
MD, USA) as described [36]. All samples were run in
triplicate, and results were averaged. Sequences of the
primers used for qRT-PCR are listed in Additional file 6:
Table S5. For conventional ChIP assays, LD611 cells were
harvested, fixed with 1% formaldehyde and processed for
immunoprecipitation using antibodies against H2A.Z,
WDR5, BPTF, and H3K4me1/me2/me3 as recently
described [36]. qPCR was performed in triplicate using
the primers listed in Additional file 6: Table S5.Nucleosome purification and protein identification
Nuclei were prepared from LD611 cells expressing Flag
and HA-tagged H2A or H2A.Z and were digested with
micrococcal nuclease to produce predominantly mono-
nucleosomes. Mononucleosomes containing ectopic H2A
or H2A.Z were subjected to anti-Flag M2 agarose. After
extensive washing with wash buffer (20 mM HEPES-KOH,
pH 7.9, 0.5 mM EDTA, 300 mM NaCl, 1 mM dithio-
threitol, 10% glycerol, and 0.1% Nonidet P-40), the eluates
were further purified using anti-HA agarose affinity chro-
matography. The imunoprecipitated nucleosome samples
were analyzed by liquid chromatography-tandem mass
spectrometry (LC-MS/MS) as described [40].
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Cell proliferation was assessed by the 3–4, 5-(dimethyl-
thyazol-2-yl)-2, 5-diphenyltetrazolium (MTT) assay as
previously described [36]. In brief, cells were seeded in
24-well tissue culture plates at a density of 2 × 104 and
treated with the MTT labeling reagent (0.5 mg/ml) at
37°C for 1 h. The blue MTT formazan precipitate was
dissolved with the MTT solvent (0.2 ml) and measured
at a wavelength of 570 nm using a microplate reader
(Bio-Rad). To measure the cell migration activity, Transwell
migration assays were performed using 5 × 104 cells. Cells
suspended in serum-free medium were plated on the
Transwell filters (8-μm pore size; Corning, Corning, NY,
USA), and DMEM supplemented with 10% FBS was used
as chemoattractant. Cells were stained with 0.5% crystal
violet and quantified after migration for 18 h.
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